alprostadil + WC3036

Alprostadil + WC3036 is a combination drug intended for the treatment of erectile dysfunction. Alprostadil is a synthetic analog of prostaglandin E1 (PGE1) that induces vasodilation and relaxation of smooth muscle in the corpus cavernosum primarily via increased cyclic AMP (cAMP) levels, facilitating penile erection. The mechanism of action for WC3036 is not explicitly documented in available sources; however, based on naming conventions and therapeutic context, it is likely a phosphodiesterase type 5 (PDE5) inhibitor, a class commonly paired with alprostadil to enhance erectile response in cases where monotherapy is insufficient. The rationale for such combinations is to exploit synergistic interactions between agents that modulate the cAMP and cGMP pathways. This combination is particularly used for men with erectile dysfunction refractory to first-line oral monotherapies, such as PDE5 inhibitors, or post-prostatectomy cases[1][3].

Other names

alprostadil + WC3036